We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBI
476
DELISTED
Hanesbrands
HBI
$345K 0.03%
+14,000
New +$289K
WFM
477
DELISTED
Whole Foods Market Inc
WFM
$345K 0.03%
8,940
-5,403
-38% -$235K
NPSP
478
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$345K 0.03%
10,432
+1,940
+23% +$56K
HRB icon
479
H&R Block
HRB
$5.98B
$344K 0.03%
+10,260
New +$306K
INCY icon
480
Incyte
INCY
$25.4B
$344K 0.03%
+6,100
New +$312K
BRCM
481
DELISTED
BROADCOM CORP CL-A
BRCM
$343K 0.03%
9,230
-3,900
-30% -$128K
NEE icon
482
NextEra Energy
NEE
$184B
$342K 0.03%
13,360
-20,400
-60% -$496K
QVCGA
483
DELISTED
QVC Group Inc Series A
QVCGA
$342K 0.03%
284
-34
-11% -$40.6K
IWB icon
484
iShares Russell 1000 ETF
IWB
$47.1B
$341K 0.03%
+3,100
New +$330K
SRE icon
485
Sempra
SRE
$58.1B
$340K 0.03%
6,500
-3,000
-32% -$149K
CMD
486
DELISTED
Cantel Medical Corporation
CMD
$340K 0.03%
9,278
– –
OME
487
DELISTED
Omega Protein
OME
$340K 0.03%
24,819
– –
CE icon
488
Celanese
CE
$4.82B
$339K 0.03%
+5,270
New +$320K
KDP icon
489
Keurig Dr Pepper
KDP
$42.8B
$337K 0.03%
5,750
– –
KFRC icon
490
Kforce
KFRC
$1.05B
$337K 0.03%
15,548
– –
TTWO icon
491
Take-Two Interactive
TTWO
$46.1B
$336K 0.03%
+15,101
New +$309K
BCS icon
492
Barclays
BCS
$87.8B
$335K 0.03%
24,801
-52,009
-68% -$788K
FFIV icon
493
F5
FFIV
$22B
$335K 0.03%
+3,010
New +$324K
SIRO
494
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$335K 0.03%
4,062
– –
EW icon
495
Edwards Lifesciences
EW
$49.4B
$334K 0.03%
+23,316
New +$316K
HP icon
496
Helmerich & Payne
HP
$3.34B
$334K 0.03%
+2,880
New +$315K
ADM icon
497
Archer Daniels Midland
ADM
$38.7B
$333K 0.03%
7,540
-6,000
-44% -$265K
UNFI icon
498
United Natural Foods
UNFI
$3.04B
$333K 0.03%
5,117
– –
DVA icon
499
DaVita
DVA
$15.5B
$332K 0.03%
4,588
– –
NOC icon
500
Northrop Grumman
NOC
$76B
$331K 0.03%
2,770
-1,600
-37% -$193K
18 19
20
21 22

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.